Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Methyl salicylate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Deep Heat Maximum Strength cream
1003020N0BIAHBA
|
Mentholatum (Topical) | Methyl salicylate | Musculoskeletal and Joint Diseases | 2,357 |
|
Methyl salicylate 30% / Menthol 8% cream
1003020N0AABABA
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | 1,546 |
|
Balmosa cream
1003020N0BDAAAK
|
Balmosa | Methyl salicylate | Musculoskeletal and Joint Diseases | 1,408 |
|
Deep Heat Pain Relief spray
1003020N0BIAJA0
|
Mentholatum (Topical) | Methyl salicylate | Musculoskeletal and Joint Diseases | 277 |
|
Radian B Pain Relief spray
1003020N0BFAFAY
|
Radian-B (Methyl salicylate) | Methyl salicylate | Musculoskeletal and Joint Diseases | 161 |
|
Deep Heat spray
1003020N0BIADA0
|
Mentholatum (Topical) | Methyl salicylate | Musculoskeletal and Joint Diseases | 32 |
|
Methyl salicylate 50% ointment
1003020N0AAABAB
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | 9 |
|
Mentholatum Vapour Rub
1003020N0BIAIA0
|
Mentholatum (Topical) | Methyl salicylate | Musculoskeletal and Joint Diseases | 7 |
|
Deep Heat rub
1003020N0BIAAAT
|
Mentholatum (Topical) | Methyl salicylate | Musculoskeletal and Joint Diseases | 1 |
|
Bell's Muscle Rub ointment
1003020N0BUABA0
|
Bell's (Methyl salicylate) | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Bell's Seven in One Rubbing Oil
1003020N0BUAABB
|
Bell's (Methyl salicylate) | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Boots Warming Pain Relief spray
1003020N0BRAAA0
|
Boots Warming Pain Relief | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Dubam cream
1003020N0BEACA0
|
Dubam | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Dubam spray
1003020N0BEABAM
|
Dubam | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Generic Balmosa cream
1003020N0AAAKAK
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Generic Deep Heat rub
1003020N0AAATAT
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Generic Dubam spray
1003020N0AAAMAM
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Generic PR Heat spray
1003020N0AAAUAU
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Generic Radian B Muscle lotion
1003020N0AAASAS
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Generic Radian B Pain Relief spray
1003020N0AAAYAY
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxyethyl salicylate 6% / Methyl nicotinate 1.6% spray
1003020N0AAAZAZ
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Lloydspharmacy Vapour Rub
1003020N0BPABA0
|
Lloydspharmacy Rub | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Methyl salicylate 25% liniment
1003020N0AAAAAA
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Methyl salicylate 70mg/g topical solution
1003020N0AABBBB
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Methyl salicylate liquid
1003020N0AAAFAF
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.